Peroxisomal ABC Transporters: An Update
Open accessThe DOI matches its Crossref record; 176 of the 178 references it cites were found in a registry or an index; 9 of the 213 sources its claims cite were checked for support.
Abstract
ATP-binding cassette (ABC) transporters constitute one of the largest superfamilies of conserved proteins from bacteria to mammals. In humans, three members of this family are expressed in the peroxisomal membrane and belong to the subfamily D: ABCD1 (ALDP), ABCD2 (ALDRP), and ABCD3 (PMP70). These half-transporters must dimerize to form a functional transporter, but they are thought to exist primarily as tetramers. They possess overlapping but specific substrate specificity, allowing the transport of various lipids into the peroxisomal matrix. The defects of ABCD1 and ABCD3 are responsible for two genetic disorders called X-linked adrenoleukodystrophy and congenital bile acid synthesis defect 5, respectively. In addition to their role in peroxisome metabolism, it has recently been proposed that peroxisomal ABC transporters participate in cell signaling and cell control, particularly in cancer. This review presents an overview of the knowledge on the structure, function, and mechanisms involving these proteins and their link to pathologies. We summarize the different in vitro and in vivo models existing across the species to study peroxisomal ABC transporters and the consequences of their defects. Finally, an overview of the known and possible interactome involving these proteins, which reveal putative and unexpected new functions, is shown and discussed.
Overview
CoChat Summary
## TL;DR
This is a narrative review of peroxisomal ABC transporters, focusing on ABCD1, ABCD2, and ABCD3, and how their structure, transport mechanism, interacting partners, and disease links shape lipid metabolism and cell signaling. It highlights that these transporters are central not only to β-oxidation of fatty acids but also to X-linked adrenoleukodystrophy, congenital bile acid synthesis defect type 5, cancer-associated expression changes, and peroxisome-organelle communication.
## Key findings
- Human peroxisomal ABC transporters ABCD1, ABCD2, and ABCD3 are half-transporters that must dimerize; the paper states ABCD1 and ABCD3 are mainly found as homodimers, while ABCD1/ABCD2 heterodimers and tetramers also occur.
- Substrate specificity differs across transporters: ABCD1 transports saturated and monounsaturated VLCFAs; ABCD2 overlaps with ABCD1 but is also linked to PUFA transport, especially DHA and its precursor C24:6 n-3; ABCD3 has the broadest specificity, including LCFAs, VLCFAs, dicarboxylic acids, branched-chain fatty acids, and C27 bile acid intermediates.
- The paper states X-linked adrenoleukodystrophy has an estimated incidence of 1:17,000, and ABCD1 mutations are found in every X-ALD patient; nearly 900 non-recurrent mutations are noted, but no genotype-phenotype correlation has been described.
- In X-ALD, Abcd1 knockout mice reproduce the biochemical phenotype, and a prospective phase II pilot study in 13 AMN patients treated with antioxidant molecules reportedly normalized biomarkers of oxidative damage and inflammation and improved locomotion.
## Methods
- Not stated in the paper.
- The article is a literature review that synthesizes prior structural, biochemical, genetic, animal-model, cell-model, proteomic, and clinical studies on peroxisomal ABC transporters.
- Its evidence base includes functional complementation assays, knock-out and transgenic animal models, co-immunoprecipitation/proteomics, yeast and plant models, patient fibroblasts, and cited clinical studies.
## Limitations
- The paper explicitly notes that exact substrate specificity and the functional relevance of some dimeric/oligomeric states remain unclear, and that the exact transport mechanism remains controversial.
- It states that no model exactly mimics human X-ALD.
- Evident from the text: because this is a review, it does not present a new primary dataset or a unified quantitative meta-analysis of the cited studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Structural model of human ABCD1 (reprinted from [17]). (A) Ribbon representation of the ABCD1 monomer. TMD helices are numbered from 1 to 6 and rainbow colored from dark blue to red. NBD is in light grey, and intracellular loops (ICL) 1 and 2 are indicated. (B) Ribbon representation of the ABCD1 homodimer with the two subunits respectively colored in dark blue and yellow.](https://figures.cochat.ai/paper-figures/d9b6132383424bcbbf06be774b3e354d/peroxisomal-abc-transporters-an-update-figure-2.jpg)
Verification
Claims the paper makes
7 Valid · 3 Not valid · 135 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Using transgenic expression of Abcd2 in the Abcd1 knock-out mouse, Pujol et al. demonstrated that VLCFA accumulation and disease phenotype could be corrected in vivo [ 40 ].”
What the sources say
- Supportedcites [40] Pujol, 2004, Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: A therapeutic target for X-adrenoleukodystrophy, Hum. Mol. Genet. source
The Results section reports that ALDR overexpression in ALD-deficient mice normalized VLCFA levels in all organs analyzed. The Discussion reports long-term prevention of the neurodegenerative features caused by ALD loss, supporting the claim of an in vivo disease-phenotype rescue. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Oxidative stress and cellular components, especially microglial functions, seem to play a major role in the pathogenesis of X-ALD [ 89 , 90 , 91 ].”
What the sources say
- Not checked yetcites [89] Singh, 2010, Pathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis, Brain Pathol. source
- Not checked yetcites [90] Bergner, 2019, Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy, Glia source
- Partly supportedcites [91] Gong, 2017, Microglial dysfunction as a key pathological change in adrenomyeloneuropathy, Ann. Neurol. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) links altered microglial function to neuronal damage in adrenomyeloneuropathy (AMN) and says oxidative stress may prime phagocytosis. But the study focuses on AMN rather than establishing these roles across X-ALD, and it says the contribution of other cell types was beyond its scope. (LLM, conf=0.84)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Abcd1/Abcd2 double knock-out mice have an earlier and more severe neurological phenotype associated with inflammatory T lymphocyte infiltration in the spinal cord [ 40 ]”
What the sources say
- Supportedcites [40] Pujol, 2004, Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: A therapeutic target for X-adrenoleukodystrophy, Hum. Mol. Genet. source
The DISCUSSION of our copy states that in double knockouts 'the AMNlike pathology is more severe with an earlier onset (12 months rather than 20 months in the ALD KO)' and that they 'present inflammatory infiltrates in the spinal cord composed mainly of T lymphocytes, pathological features that are not present in single ALD or ALDR mutants.' The Spinal cord histopathology section corroborates the T-lymphocyte perivascular/perimeningeal infiltrates in double mutants only, and the neurological phenotype section reports considerably worsened rotarod performance with severe impairment already at 15 months versus 20 months in ALD-/- mice. All elements of the claim (earlier, more severe, spinal cord T-cell infiltrates) are stated. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Pharmacological induction of ABCD2 was indeed shown to compensate for ABCD1 defect in vitro and in rare cases, in vivo, opening the way for clinical trials [ 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ].”
What the sources say
- Not checked yetcites [43] Kemp, 1998, Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy, Nat. Med. source
- Partly supportedcites [44] Weber, F.D., Weinhofer, I., Einwich, A., Forss-Petter, S., Muneer, Z., Maier, H., Weber, W.H., and Berger, J. (2014). Evaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy. PLoS ONE, 9. sourceExperimental — accuracy not yet measured
The Introduction (p. n/a) states that 'Upon overexpression, ABCD2 is able to restore VLCFA metabolism both in vitro and in vivo' and that 'induction of ABCD2 gene expression by pharmacological means has been proposed as an alternative treatment option for X-ALD' — so the compensation concept and the pharmacological-induction rationale are in our copy, but the in vitro/in vivo restoration is attributed to genetic overexpression (refs [12],[13]), not to pharmacological induction. Our copy does not support the claim's 'in rare cases in vivo' for pharmacological induction; on the contrary, the Results section 'Evaluation of the ability of 13CRA to induce ABCD2 mRNA in human primary monocytes in vivo' (Fig. 3) reports that ABCD2 mRNA was unchanged in monocytes, B cells and T-cell-enriched PBMCs of 13CRA-treated acne patients, and the Discussion concludes that 'retinoids are probably not able to induce ABCD2 to a level high enough for a compensation of ABCD1 deficiency in macrophages in vivo'. (LLM, conf=0.75)
- Not checked yetcites [45] Rampler, 2003, Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy, Mol. Genet. Metab. source
- Not checked yetcites [46] Fourcade, 2001, Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2)—Promoter analysis and role of the peroxisome proliferator-activated receptor PPAR alpha, Eur. J. Biochem. source
- Not checked yetcites [47] Fourcade, 2003, Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2), Mol. Pharmacol. source
- Not checked yetcites [48] Gondcaille, 2005, Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator, J. Cell Biol. source
- Not checked yetcites [49] Leclercq, 2008, Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters, Biochimie source
- Not checked yetcites [50] Genin, 2009, Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics, J. Steroid Biochem. Mol. Biol. source
- Not checked yetcites [51] Gondcaille, 2014, LXR antagonists induce ABCD2 expression, Biochim. Biophys. Acta source
- Not checked yetcites [52] Trompier, 2014, Regulation of the adrenoleukodystrophy-related gene (ABCD2): Focus on oxysterols and LXR antagonists, Biochem. Biophys. Res. Commun. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“These promising results suggest that such a therapeutic strategy may be as effective as allogeneic HSCT.”
What the sources say
- Supportedcites [82] Cartier, 2009, Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy, Science source
In the section on ex vivo lentiviral-mediated ABCD1 transfer, the paper says the neurologic benefits of HSC gene therapy in ALD were comparable to those seen with allogeneic HCT. Its finding in two patients supports the citing sentence’s cautious suggestion that the strategy may be as effective. (LLM, conf=0.91)
- Not checked yetcites [83] Eichler, 2017, Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy, N. Engl. J. Med. source
hedgedstates a possible causen = 15- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
69 more claims
Create a free account to see all 173 claims and to verify the 204 references still open.
- It may state two separate claims as one. 82
- Probably not a substantial claim. 29
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Very-long-chain fatty acid import into peroxisomes is mediated by the ABC transporters ABCD1 and ABCD2, which have overlapping but distinct substrate preferences (Tawbeh et al., 2021) (Figure 1).”
From The neurological pathology of peroxisomal ACBD5 deficiency – lessons from patients and mouse models (2025) · cites this paper as Tawbeh et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“PEX19p is the only ABCD2 binding partner that has been reported in the literature”
“Data shows that ABCD1, ABCD2, and ABCD3 are able to interact as homodimers or heterodimers [ 20 , 21 , 22 ]”
Citations
Cites
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 3×
“Recent therapeutic successes [82,83], and the feasibility and reliability of a diagnosis method based on VLCFA quantification from blood spot [84,85], have prompted some countries to establish systematic screening of newborns.”
BackgroundArchitecture of the human interactome defines protein communities and disease networks
Huttlin, E. L., Bruckner, R. J., Paulo, J. A., Cannon, J. R., Ting, L., Baltier, K., Colby, G., Gebreab, F., Gygi, M. P., Parzen, H., et al. (2017) · Nature · doi:10.1038/nature22366 · Cited by 1,437
The BioPlex network: a systematic exploration of the human interactome
Huttlin, E. L., Ting, L., Bruckner, R. J., Gebreab, F., Gygi, M. P., Szpyt, J., Tam, S., Zarraga, G., Colby, G., Baltier, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.043 · Cited by 1,425
A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
Hein, M. Y., Hubner, N. C., Poser, I., Cox, J., Nagaraj, N., Toyoda, Y., Gak, I. A., Weisswange, I., Mansfeld, J., Buchholz, F., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.053 · Cited by 1,270
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202 · cited 2×
“In 1993, using positional cloning, the team of Hugo Moser identified the ABCD1 gene as being responsible for X-ALD [30].”
BackgroundMethodBiochemistry of mammalian peroxisomes revisited
Wanders, R. J. A., & Waterham, H. R. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133329 · Cited by 995 · cited 3×
“β-oxidation of FAs is a conserved process of peroxisomes by which acyl groups are degraded two carbons at a time after being activated to form the corresponding CoA derivative by a specific acyl-CoA synthetase located at the peroxisomal membrane [7].”
BackgroundLarge‐scale mapping of human protein–protein interactions by mass spectrometry
Ewing, R. M., Chu, P., Elisma, F., Li, H., Taylor, P., Climie, S., McBroom‐Cerajewski, L., Robinson, M. D., O'Connor, L., Li, M., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100134 · Cited by 984
Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 959
A Census of Human Soluble Protein Complexes
Havugimana, P. C., Hart, G. T., Nepusz, T., Yang, H., Turinsky, A. L., Li, Z., Wang, P. I., Boutz, D. R., Fong, V., Phanse, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.011 · Cited by 860
Efficient derivation of microglia-like cells from human pluripotent stem cells
Muffat, J., Li, Y., Yuan, B., Mitalipova, M., Omer, A., Corcoran, S., Bakiasi, G., Tsai, L.-H., Aubourg, P., Ransohoff, R. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4189 · Cited by 651
EVOLUTION OF THE ATP-BINDING CASSETTE (ABC) TRANSPORTER SUPERFAMILY IN VERTEBRATES
Dean, M., & Annilo, T. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162122 · Cited by 650 · cited 1×
“Based on their amino acid homology and structural configuration, ABC transporters in humans are classified into seven subfamilies, A to G, comprising a total of 48 ABC transporters, many of which are implicated in diseases [2].”
BackgroundRole of peroxisomes in ros/rns-metabolism: Implications for human disease
Fransen, M., Nordgren, M., Wang, B., & Apanasets, O. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.001 · Cited by 644
Peroxisomes: A Nexus for Lipid Metabolism and Cellular Signaling
Lodhi, I. J., & Semenkovich, C. F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.002 · Cited by 605
Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy
Eichler, F., Duncan, C., Musolino, P. L., Orchard, P. J., De Oliveira, S., Thrasher, A. J., Armant, M., Dansereau, C., Lund, T. C., Miller, W. P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700554 · Cited by 604 · cited 2×
“Lentiviral correction of bone marrow derived stem cells and autologous transplantation proved effective in 15 patients in 2017 [83].”
BackgroundStructural and Mechanistic Principles of ABC Transporters
Thomas, C., & Tampé, R. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-011520-105201 · Cited by 563 · cited 3×
“NBDs bind and hydrolyze ATP to trigger conformational changes in the TMDs, resulting in unidirectio al transport across the membrane [1].”
BackgroundEngelen, M., Kemp, S., de Visser, M., van Geel, B. M., Wanders, R. J., Aubourg, P., & Poll-The, B. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-51 · Cited by 562
A transcriptomic atlas of aged human microglia
Olah, M., Patrick, E., Villani, A.-C., Xu, J., White, C. C., Ryan, K. J., Piehowski, P., Kapasi, A., Nejad, P., Cimpean, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02926-5 · Cited by 482
Kamijo, K., Taketani, S., Yokota, S., Osumi, T., & Hashimoto, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39595-x · Cited by 391 · cited 1×
“PMP70, the protein coded by the ABCD3 gene, was the first identified peroxisomal ABC transporter and is the most abundant peroxisomal membrane protein, at least in hepatocytes [62,63].”
BackgroundWanders, R. J. A., Waterham, H. R., & Ferdinandusse, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00083 · Cited by 366 · cited 1×
“In yeast and plants, this process of FA β-oxidation occurs exclusively in peroxisomes, whereas in higher eukaryotes, the catabolism of VLCFAs is initiated solely in the peroxisomes [7,80].”
BackgroundAubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G., Naud-Saudreau, C., Rolland, M.-O., Debré, M., Chaussain, J.-L., Griscelli, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222607 · Cited by 366 · cited 1×
“Since 1990 and the first success of this therapy [92], allogeneic graft has been indicated for boys with ccALD at an early stage of the disease when a compatible donor exists.”
BackgroundA Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals
Wei, B. Q., Mikkelsen, T. S., McKinney, M. K., Lander, E. S., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606646200 · Cited by 363
The Peroxisome-Mitochondria Connection: How and Why?
Fransen, M., Lismont, C., & Walton, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061126 · Cited by 351
Hettema, E. H., van Roermund, C. W., Distel, B., van den Berg, M., Vilela, C., Rodrigues‐Pousada, C., Wanders, R. J., & Tabak, H. F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00755.x · Cited by 323
A mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293
Theodoulou, F. L., Job, K., Slocombe, S. P., Footitt, S., Holdsworth, M., Baker, A., Larson, T. R., & Graham, I. A. (2005) · Plant Physiology · doi:10.1104/pp.105.059352 · Cited by 290 · cited 1×
“CTS is involved in the import of FAs and phytohormone precursors into the peroxisome where they are β-oxidized [110,111].”
BackgroundThe peroxisome: an update on mysteries 2.0
Islinger, M., Voelkl, A., Fahimi, H. D., & Schrader, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1722-5 · Cited by 283
Dietary docosahexaenoic and eicosapentaenoic acid: Emerging mediators of inflammation
Chapkin, R. S., Kim, W., Lupton, J. R., & McMurray, D. N. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.010 · Cited by 282 · cited 1×
“It is important to note that DHA is not only of great value by itself as a component of cell membranes, but is also the source of eicosanoids associated with several key signaling functions [10].”
BackgroundThe peroxisome: an update on mysteries
Islinger, M., Grille, S., Fahimi, H. D., & Schrader, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0941-4 · Cited by 281
Deakin, S., Leviev, I., Gomaraschi, M., Calabresi, L., Franceschini, G., & James, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107440200 · Cited by 251
Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A., & Smith, K. D. (1998) · Nature Medicine · doi:10.1038/3242 · Cited by 249
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters
van Roermund, C. W. T., Visser, W. F., IJlst, L., van Cruchten, A., Boek, M., Kulik, W., Waterham, H. R., & Wanders, R. J. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-110866 · Cited by 233 · cited 3×
“Moreover, ABCD1 and ABCD2 homodimers are functional [26,27].”
BackgroundMutations in ABCD4 cause a new inborn error of vitamin B12 metabolism
Coelho, D., Kim, J. C., Miousse, I. R., Fung, S., du Moulin, M., Buers, I., Suormala, T., Burda, P., Frapolli, M., Stucki, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2386 · Cited by 233 · cited 1×
“More recently, several studies have demonstrated that ABCD4 resides in the endoplasmic reticulum and lysosomes, and that its function is associated with cobalamin metabolism [3,5,6].”
BackgroundMutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome
Gärtner, J., Moser, H., & Valle, D. (1992) · Nature Genetics · doi:10.1038/ng0492-16 · Cited by 226 · cited 2×
“Although mutations were found in the ABCD3 gene of a Zellweger patient [64], further evidence showed that ABCD3 has no link with peroxisomal biogenesis and is definitively not associated with Zellweger Syndrome [95].”
BackgroundLombard-Platet, G., Savary, S., Sarde, C. O., Mandel, J. L., & Chimini, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1265 · Cited by 222 · cited 3×
“Cloned by homology using degenerate primers, the ABCD2 gene was shown to code for ALDRP, the closest homolog of ALDP [38].”
MethodSelf-citationPujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214
Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy
Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn085 · Cited by 214
Adrenoleukodystrophy: Elevated C26 fatty acid in cultured skin fibroblasts
Moser, H. W., Moser, A. B., Kawamura, N., Murphy, J., Suzuki, K., Schaumburg, H., & Kishimoto, Y. (1980) · Annals of Neurology · doi:10.1002/ana.410070607 · Cited by 210
Ferdinandusse, S., Denis, S., Mooijer, P. A. W., Zhang, Z., Reddy, J. K., Spector, A. A., & Wanders, R. J. A. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31527-3 · Cited by 208
Spastin tethers lipid droplets to peroxisomes and directs fatty acid trafficking through ESCRT-III
Chang, C.-L., Weigel, A. V., Ioannou, M. S., Pasolli, H. A., Xu, C. S., Peale, D. R., Shtengel, G., Freeman, M., Hess, H. F., Blackstone, C., et al. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201902061 · Cited by 206
Peroxisomal Hydrogen Peroxide Metabolism and Signaling in Health and Disease
Lismont, C., Revenco, I., & Fransen, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153673 · Cited by 203
Pujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201 · cited 18×
“In addition, the biochemical and neurological defects observed in the Abcd1 knock-out mice can be corrected by ubiquitous transgenic expression of Abcd2 [40].”
BackgroundInfluentialKobayashi, T., Shinnoh, N., Kondo, A., & Yamada, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6340 · Cited by 197
X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes
Smith, K. D., Kemp, S., Braiterman, L. T., Lu, J.-F., Wei, H.-M., Geraghty, M., Stetten, G., Bergin, J. S., Pevsner, J., & Watkins, P. A. (1999) · Neurochemical Research · doi:10.1023/a:1022535930009 · Cited by 190
Peroxisomes as cellular adaptors to metabolic and environmental stress
He, A., Dean, J. M., & Lodhi, I. J. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.02.005 · Cited by 181
Hubbard, W. C., Moser, A. B., Liu, A. C., Jones, R. O., Steinberg, S. J., Lorey, F., Panny, S. R., Vogt Jr., R. F., Macaya, D., & Turgeon, C. T. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.03.010 · Cited by 177 · cited 1×
“Recent therapeutic successes [82,83], and the feasibility and reliability of a diagnosis method based on VLCFA quantification from blood spot [84,85], have prompted some countries to establish systematic screening of newborns.”
BackgroundKunz, H.-H., Scharnewski, M., Feussner, K., Feussner, I., Flügge, U.-I., Fulda, M., & Gierth, M. (2009) · The Plant Cell · doi:10.1105/tpc.108.064857 · Cited by 173
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy
Ofman, R., Dijkstra, I. M. E., van Roermund, C. W. T., Burger, N., Turkenburg, M., van Cruchten, A., van Engen, C. E., Wanders, R. J. A., & Kemp, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000061 · Cited by 170 · cited 1×
“This accumulation results from the impossibility of their entry into the peroxisome for their degradation by β-oxidation, but also from an increased endogenous biosynthesis [87].”
BackgroundJang, J., Park, S., Jin Hur, H., Cho, H.-J., Hwang, I., Pyo Kang, Y., Im, I., Lee, H., Lee, E., Yang, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13129 · Cited by 166
De Marcos Lousa, C., van Roermund, C. W. T., Postis, V. L. G., Dietrich, D., Kerr, I. D., Wanders, R. J. A., Baldwin, S. A., Baker, A., & Theodoulou, F. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218034110 · Cited by 158 · cited 3×
“In addition, intrinsic acyl-CoA thioesterase activity has been found in COMATOSE (CTS), a homolog of human ABCD1 in Arabidopsis thaliana, proving again that VLCFA-CoA is hydrolyzed prior to transport [73].”
BackgroundInfluentialViolante, S. N., Achetib, N., van Roermund, C. W. T., Hagen, J., Dodatko, T., Vaz, F. M., Waterham, H. R., Chen, H., Baes, M. I., Yu, C., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801498r · Cited by 154 · cited 2×
“This could be in agreement with the role of ABCD3 in the β-oxidation of lauric and palmitic acids [68].”
BackgroundBrown, I., Cascio, M. G., Wahle, K. W. J., Smoum, R., Mechoulam, R., Ross, R. A., Pertwee, R. G., & Heys, S. D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq151 · Cited by 150
Pathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis
Singh, I., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00392.x · Cited by 148
Netik, A., Forss-Petter, S., Holzinger, A., Molzer, B., Unterrainer, G., & Berger, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.907 · Cited by 148 · cited 1×
“It explains the correction of β-oxidation defect in X-ALD fibroblasts in case of ABCD2 overexpression after transfection [39].”
BackgroundRole of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy
McGuinness, M. C., Lu, J.-F., Zhang, H.-P., Dong, G.-X., Heinzer, A. K., Watkins, P. A., Powers, J., & Smith, K. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.744-753.2003 · Cited by 147
The Glia of Caenorhabditis elegans
Oikonomou, G., & Shaham, S. (2011) · Glia · doi:10.1002/glia.21084 · Cited by 144 · cited 1×
“Moreover, hypodermal cells have similarities with vertebrate glial cells and participate in neuronal migration [114].”
BackgroundPeroxisomal acyl-CoA synthetases
Watkins, P. A., & Ellis, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.010 · Cited by 143 · cited 1×
“This reaction is catalyzed by specific acyl-CoA synthetase connected to the cytosolic side of the peroxisomal membrane [69].”
BackgroundMultiple Pathways for Protein Transport to Peroxisomes
Kim, P. K., & Hettema, E. H. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.02.005 · Cited by 143
Homo- and Heterodimerization of Peroxisomal ATP-binding Cassette Half-transporters
Liu, L. X., Janvier, K., Berteaux-Lecellier, V., Cartier, N., Benarous, R., & Aubourg, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32738 · Cited by 141 · cited 1×
“Concerning ABCD3, although homodimers and heterodimers with ABCD1 and ABCD2 have been described [22,23,25,28,29], no data is available about the functional value of the ABCD3 dimers.”
BackgroundPeroxisome Metabolism in Cancer
Kim, J. (2020) · Cells · doi:10.3390/cells9071692 · Cited by 141 · cited 1×
“Beyond its recognized role in metabolism and redox homeostasis, the peroxisome is now increasingly regarded as a signaling platform and a key organelle in cellular metabolic reprogramming with major consequences on the immune response, cell cycle, and cell differentiation [12,96].”
BackgroundThe Expression Profile of Atp-Binding Cassette Transporter Genes in Breast Carcinoma
Hlaváč, V., Brynychová, V., Václavíková, R., Ehrlichová, M., Vrána, D., Pecha, V., Koževnikovová, R., Trnková, M., Gatěk, J., Kopperová, D., et al. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.26 · Cited by 141 · cited 1×
“On the contrary, ABCD1 and ABCD3 were found upregulated in breast carcinoma [104], and a positive correlation was observed between ABCD3 expression and glioma tumor grades [105].”
BackgroundA novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3
Ferdinandusse, S., Jimenez-Sanchez, G., Koster, J., Denis, S., Van Roermund, C. W., Silva-Zolezzi, I., Moser, A. B., Visser, W. F., Gulluoglu, M., Durmaz, O., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu448 · Cited by 134 · cited 4×
“Sci. 2021, 22, 6093 10 of 22 but exhibit hepatomegaly associated with abnormalities in peroxisomal FA metabolism, which seems to represent a suitable model for CBAS5 [67].”
BackgroundInfluentialSchepers, L., Van Veldhoven, P. P., Casteels, M., Eyssen, H. J., & Mannaerts, G. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34113-4 · Cited by 130 · cited 1×
“ACOX2 is specific to bile acid intermediates [76] whereas the oxidation of branched-chain FAs depends on both ACOX2 and ACOX3 enzymes [77,78].”
BackgroundPXA1, a possible Saccharomyces cerevisiae ortholog of the human adrenoleukodystrophy gene.
Shani, N., Watkins, P. A., & Valle, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.6012 · Cited by 129
Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation
van Roermund, C. W. T., Visser, W. F., IJlst, L., Waterham, H. R., & Wanders, R. J. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.010 · Cited by 128 · cited 5×
“Functional complementation in yeast model and X-ALD fibroblasts confirmed the functional redundancy for saturated VLCFAs, but also demonstrated the specific role of ABCD2 in PUFA transport, especially DHA and its precursor (C24:6 n-3) [26].”
BackgroundInfluentialPeroxisomes in Immune Response and Inflammation
Di Cara, F., Andreoletti, P., Trompier, D., Vejux, A., Bülow, M. H., Sellin, J., Lizard, G., Cherkaoui-Malki, M., & Savary, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163877 · Cited by 128 · cited 2×
“Beyond its recognized role in metabolism and redox homeostasis, the peroxisome is now increasingly regarded as a signaling platform and a key organelle in cellular metabolic reprogramming with major consequences on the immune response, cell cycle, and cell differentiation [12,96].”
BackgroundSelf-citationLópez-Erauskin, J., Galino, J., Ruiz, M., Cuezva, J. M., Fabregat, I., Cacabelos, D., Boada, J., Martínez, J., Ferrer, I., Pamplona, R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt186 · Cited by 125
Identification of a Fourth Half ABC Transporter in the Human Peroxisomal Membrane
Shani, N., Jimenez-Sanchez, G., Steel, G., Dean, M., & Valle, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1925 · Cited by 124 · cited 1×
“ABCD4 was identified by homology search for ALDP and PMP70 related sequences in the database of expressed sequence tags, and was initially considered peroxisomal despite the absence of a membrane peroxisomal targeting signal [4].”
BackgroundACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism
Ferdinandusse, S., Falkenberg, K. D., Koster, J., Mooyer, P. A., Jones, R., van Roermund, C. W. T., Pizzino, A., Schrader, M., Wanders, R. J. A., Vanderver, A., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104132 · Cited by 120
Verleur, N., Hettema, E. H., Van Roermund, C. W. T., Tabak, H. F., & Wanders, R. J. A. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00657.x · Cited by 117
Fatty acid amide hydrolase substrate specificity
Boger, D. L., Fecik, R. A., Patterson, J. E., Miyauchi, H., Patricelli, M. P., & Cravatt, B. F. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00528-x · Cited by 113
Fatty Acids - Induced Lipotoxicity and Inflammation
Savary, S., Trompier, D., Andreoletti, P., Le Borgne, F., Demarquoy, J., & Lizard, G. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762729 · Cited by 111 · cited 1×
“While the toxicity of VLCFAs has been recognized [88], the sequence of events leading to neurodegeneration and inflammation is still debated.”
BackgroundSelf-citationYoung, P. A., Senkal, C. E., Suchanek, A. L., Grevengoed, T. J., Lin, D. D., Zhao, L., Crunk, A. E., Klett, E. L., Füllekrug, J., Obeid, L. M., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004049 · Cited by 110
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients
Jang, J., Kang, H., Kim, H., Kim, J. Y., Huh, Y. J., Kim, D., Yoo, J., Lee, J., Lim, B., Lee, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22486 · Cited by 109
Kemper, A. R., Brosco, J., Comeau, A. M., Green, N. S., Grosse, S. D., Jones, E., Kwon, J. M., Lam, W. K. K., Ojodu, J., Prosser, L. A., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.68 · Cited by 109 · cited 1×
“Recent therapeutic successes [82,83], and the feasibility and reliability of a diagnosis method based on VLCFA quantification from blood spot [84,85], have prompted some countries to establish systematic screening of newborns.”
BackgroundGriffin, D. E., Moser, H. W., Mendoza, Q., Moench, T. R., O'Toole, S., & Moser, A. B. (1985) · Annals of Neurology · doi:10.1002/ana.410180606 · Cited by 108
Ferrer, I., Kapfhammer, J. P., Hindelang, C., Kemp, S., Troffer-Charlier, N., Broccoli, V., Callyzot, N., Mooyer, P., Selhorst, J., Vreken, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi384 · Cited by 106
Cartier, N., Lopez, J., Moullier, P., Rocchiccioli, F., Rolland, M. O., Jorge, P., Mosser, J., Mandel, J. L., Bougnères, P. F., & Danos, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1674 · Cited by 105 · cited 1×
“Transfection of X-ALD skin fibroblasts with ABCD1 cDNA corrected the β-oxidation defect and restored normal levels of VLCFAs [36,37].”
BackgroundThe COMATOSE ATP-Binding Cassette Transporter Is Required for Full Fertility in Arabidopsis
Footitt, S., Dietrich, D., Fait, A., Fernie, A. R., Holdsworth, M. J., Baker, A., & Theodoulou, F. L. (2007) · PLANT PHYSIOLOGY · doi:10.1104/pp.107.099903 · Cited by 105 · cited 1×
“The products of this oxidation are involved in the transition from dormancy to germination, root growth, seedling establishment, and fertility [112].”
BackgroundA key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis
Fourcade, S., Ruiz, M., Camps, C., Schlüter, A., Houten, S. M., Mooyer, P. A. W., Pàmpols, T., Dacremont, G., Wanders, R. J. A., Giròs, M., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90736.2008 · Cited by 104 · cited 1×
“Further studies using the Abcd2 null mice demonstrated a specific role in MUFA transport, especially for erucic acid (C22:1 n-9) in adipose tissue [59,60] and an extended role in FA homeostasis [61].”
BackgroundA role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids
van Roermund, C. W. T., IJlst, L., Wagemans, T., Wanders, R. J. A., & Waterham, H. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.12.001 · Cited by 101 · cited 2×
“Wrongly associated with peroxisome biogenesis [64], ABCD3 is also involved in the transport of various lipids and shows overlapping substrate specificities with ABCD1 when overexpressed [37,65].”
BackgroundMapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells
Heimerl, S., Bosserhoff, A., Langmann, T., Ecker, J., & Schmitz, G. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282a7e0b9 · Cited by 100 · cited 1×
“melanoma [98] and renal cell carcinoma [99], ABCD2 in breast cancer [100], and ABCD3 in ovarian cancer [101] and colorectal cancer [102].”
BackgroundTrompier, D., Vejux, A., Zarrouk, A., Gondcaille, C., Geillon, F., Nury, T., Savary, S., & Lizard, G. (2014) · Biochimie · doi:10.1016/j.biochi.2013.09.009 · Cited by 99
Self-citationBraiterman, L. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.239 · Cited by 98 · cited 2×
“Wrongly associated with peroxisome biogenesis [64], ABCD3 is also involved in the transport of various lipids and shows overlapping substrate specificities with ABCD1 when overexpressed [37,65].”
BackgroundCharacterization of the 70-kDa Peroxisomal Membrane Protein, an ATP Binding Cassette Transporter
Imanaka, T., Aihara, K., Takano, T., Yamashita, A., Sato, R., Suzuki, Y., Yokota, S., & Osumi, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11968 · Cited by 96 · cited 1×
“PMP70, the protein coded by the ABCD3 gene, was the first identified peroxisomal ABC transporter and is the most abundant peroxisomal membrane protein, at least in hepatocytes [62,63].”
BackgroundA novel case of ACOX2 deficiency leads to recognition of a third human peroxisomal acyl-CoA oxidase
Ferdinandusse, S., Denis, S., van Roermund, C. W. T., Preece, M. A., Koster, J., Ebberink, M. S., Waterham, H. R., & Wanders, R. J. A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.032 · Cited by 96 · cited 1×
“ACOX2 is specific to bile acid intermediates [76] whereas the oxidation of branched-chain FAs depends on both ACOX2 and ACOX3 enzymes [77,78].”
BackgroundPeroxisomal Fatty Acid Uptake Mechanism in Saccharomyces cerevisiae
van Roermund, C. W. T., IJlst, L., Majczak, W., Waterham, H. R., Folkerts, H., Wanders, R. J. A., & Hellingwerf, K. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.332833 · Cited by 95 · cited 2×
“This hydrolysis occurs when acyl-CoAs interacts with the heterodimer Pxa1p-Pxa2p at the cytosolic side of the peroxisomal membrane [72].”
BackgroundBergner, C. G., van der Meer, F., Winkler, A., Wrzos, C., Türkmen, M., Valizada, E., Fitzner, D., Hametner, S., Hartmann, C., Pfeifenbring, S., et al. (2019) · Glia · doi:10.1002/glia.23598 · Cited by 94
Peroxisome Interactions and Cross-Talk with Other Subcellular Compartments in Animal Cells
Schrader, M., Grille, S., Fahimi, H. D., & Islinger, M. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-6889-5_1 · Cited by 93
Baumgart, E., Vanhooren, J. C. T., Fransen, M., Marynen, P., Puype, M., Vandekerckhove, J., Leunissen, J. A. M., Fahimi, H. D., Mannaerts, G. P., & Van Veldhoven, P. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13748 · Cited by 90 · cited 2×
“ACOX2 is specific to bile acid intermediates [76] whereas the oxidation of branched-chain FAs depends on both ACOX2 and ACOX3 enzymes [77,78].”
BackgroundSchaumburg, H. H. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490390092013 · Cited by 89
Peroxisomal ABC transporters: functions and mechanism
Baker, A., Carrier, D. J., Schaedler, T., Waterham, H. R., van Roermund, C. W., & Theodoulou, F. L. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150127 · Cited by 87 · cited 2×
“Therefore, peroxisomal ABC half-transporters need to homo- or heterodimerize in the peroxisomal membrane in order to constitute a full, active transporter [18,19].”
BackgroundGalino, J., Ruiz, M., Fourcade, S., Schlüter, A., López-Erauskin, J., Guilera, C., Jove, M., Naudi, A., García-Arumí, E., Andreu, A. L., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3877 · Cited by 85
Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy
Morató, L., Galino, J., Ruiz, M., Calingasan, N. Y., Starkov, A. A., Dumont, M., Naudí, A., Martínez, J. J., Aubourg, P., Portero-Otín, M., et al. (2013) · Brain · doi:10.1093/brain/awt143 · Cited by 82
Kawaguchi, K., & Morita, M. (2016) · BioMed Research International · doi:10.1155/2016/6786245 · Cited by 81 · cited 2×
“More recently, several studies have demonstrated that ABCD4 resides in the endoplasmic reticulum and lysosomes, and that its function is associated with cobalamin metabolism [3,5,6].”
BackgroundShibata, H., Kashiwayama, Y., Imanaka, T., & Kato, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402204200 · Cited by 80
Maintaining social contacts: The physiological relevance of organelle interactions
Silva, B. S. C., DiGiovanni, L., Kumar, R., Carmichael, R. E., Kim, P. K., & Schrader, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118800 · Cited by 80
Singh, J., Khan, M., & Singh, I. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800321-jlr200 · Cited by 75
Impaired plasticity of macrophages in X-linked adrenoleukodystrophy
Weinhofer, I., Zierfuss, B., Hametner, S., Wagner, M., Popitsch, N., Machacek, C., Bartolini, B., Zlabinger, G., Ohradanova-Repic, A., Stockinger, H., et al. (2018) · Brain · doi:10.1093/brain/awy127 · Cited by 72
Rodríguez‐Pascau, L., Britti, E., Calap-Quintana, P., Dong, Y., Vergara, C., Delaspre, F., Medina‐Carbonero, M., Tamarit, J., Pallardó, F. V., González‐Cabo, P., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105162 · Cited by 72 · cited 1×
“In addition, efforts to find pharmacological strategies targeting oxidative stress, inflammation, or compensatory mechanisms (antioxidant cocktail [93], leriglitazone [94], sobetirome [50,54,55]) are still present.”
BackgroundHartley, M. D., Kirkemo, L. L., Banerji, T., & Scanlan, T. S. (2017) · Endocrinology · doi:10.1210/en.2016-1842 · Cited by 70 · cited 1×
“In addition, efforts to find pharmacological strategies targeting oxidative stress, inflammation, or compensatory mechanisms (antioxidant cocktail [93], leriglitazone [94], sobetirome [50,54,55]) are still present.”
BackgroundFourcade, S., Savary, S., Albet, S., Gauthé, D., Gondcaille, C., Pineau, T., Bellenger, J., Bentejac, M., Holzinger, A., Berger, J., et al. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02249.x · Cited by 70
Self-citationGondcaille, C., Depreter, M., Fourcade, S., Lecca, M. R., Leclercq, S., Martin, P. G. P., Pineau, T., Cadepond, F., ElEtr, M., Bertrand, N., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501036 · Cited by 70
Self-citationKashiwayama, Y., Seki, M., Yasui, A., Murasaki, Y., Morita, M., Yamashita, Y., Sakaguchi, M., Tanaka, Y., & Imanaka, T. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.031 · Cited by 69 · cited 1×
“More recently, several studies have demonstrated that ABCD4 resides in the endoplasmic reticulum and lysosomes, and that its function is associated with cobalamin metabolism [3,5,6].”
BackgroundHigh-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism
Braicu, E. I., Darb‐Esfahani, S., Schmitt, W., Koistinen, K. M., Heiskanen, L., Pöhö, P., Budczies, J., Kuhberg, M., Dietel, M., Frezza, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22076 · Cited by 64 · cited 1×
“Moreover, a lower prognostic value has been associated with low expression of ABCD1 in ovarian cancer [103] and low expression of ABCD3 in colorectal cancer [102].”
BackgroundTanaka, A. R., Tanabe, K., Morita, M., Kurisu, M., Kasiwayama, Y., Matsuo, M., Kioka, N., Amachi, T., Imanaka, T., & Ueda, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205079200 · Cited by 63 · cited 1×
“Concerning ABCD3, although homodimers and heterodimers with ABCD1 and ABCD2 have been described [22,23,25,28,29], no data is available about the functional value of the ABCD3 dimers.”
BackgroundMouse liver PMP70 and ALDP: homomeric interactions prevail in vivo
Guimarães, C. P., Domingues, P. M., Aubourg, P. R., Fouquet, F., Pujol, A., Jiménez‐Sánchez, G., Sá-Miranda, C., & Azevedo, J. E. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.04.001 · Cited by 63
Weber, F. D., Wiesinger, C., Forss-Petter, S., Regelsberger, G., Einwich, A., Weber, W. H. A., Kohler, W., Stockinger, H., & Berger, J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt645 · Cited by 63
Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated
Jangouk, P., Zackowski, K. M., Naidu, S., & Raymond, G. V. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.001 · Cited by 63 · cited 1×
“Female carriers usually remain quasi asymptomatic or present only a mild phenotype, but severe forms have also been described [86].”
BackgroundLaunay, N., Ruiz, M., Grau, L., Ortega, F. J., Ilieva, E. V., Martínez, J. J., Galea, E., Ferrer, I., Knecht, E., Pujol, A., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1655-9 · Cited by 62
Rattay, T. W., Rautenberg, M., Söhn, A. S., Hengel, H., Traschütz, A., Röben, B., Hayer, S. N., Schüle, R., Wiethoff, S., Zeltner, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71248-8 · Cited by 61 · cited 1×
“Accumulation of saturated and monounsaturated VLCFAs indeed occurs in the plasma and tissues of X-ALD patients, and is used for diagnosis [31,32].”
BackgroundWeinhofer, I. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2701 · Cited by 59
Gloeckner, C. J., Mayerhofer, P. U., Landgraf, P., Muntau, A. C., Holzinger, A., Gerber, J.-K., Kammerer, S., Adamski, J., & Roscher, A. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2572 · Cited by 57
Kruska, N., Schönfeld, P., Pujol, A., & Reiser, G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.005 · Cited by 56
Paraoxonase Role in Human Neurodegenerative Diseases
Reichert, C. O., Levy, D., & Bydlowski, S. P. (2020) · Antioxidants · doi:10.3390/antiox10010011 · Cited by 55
Hillebrand, M., Verrier, S. E., Ohlenbusch, A., Schäfer, A., Söling, H.-D., Wouters, F. S., & Gärtner, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702122200 · Cited by 54
Microglial dysfunction as a key pathological change in adrenomyeloneuropathy
Gong, Y., Sasidharan, N., Laheji, F., Frosch, M., Musolino, P., Tanzi, R., Kim, D. Y., Biffi, A., El Khoury, J., & Eichler, F. (2017) · Annals of Neurology · doi:10.1002/ana.25085 · Cited by 54 · cited 1×
“However, microglia activation seems to occur early, probably from eight months of age [91].”
BackgroundGenin, E. C., Geillon, F., Gondcaille, C., Athias, A., Gambert, P., Trompier, D., & Savary, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211912 · Cited by 53 · cited 2×
“Experiments in mammalian cells confirmed such substrate preference [19,20].”
BackgroundSelf-citationRaas, Q., Gondcaille, C., Hamon, Y., Leoni, V., Caccia, C., Ménétrier, F., Lizard, G., Trompier, D., & Savary, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.02.006 · Cited by 53
Self-citationLee, C. A. A., Seo, H. S., Armien, A. G., Bates, F. S., Tolar, J., & Azarin, S. M. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0094-5 · Cited by 52
Human liver paraoxonase (PON1): Subcellular distribution and characterization
Gonzalvo, M. C., Gil, F., Hernández, A. F., Rodrigo, L. S., Villanueva, E., & Pla, A. (1998) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(1998)12:1<61::aid-jbt8>3.0.co;2-n · Cited by 52
Topology of ATP-Binding Domain of Adrenoleukodystrophy Gene Product in Peroxisomes
Contreras, M., Sengupta, T. K., Sheikh, F. G., Aubourg, P. R., & Singh, I. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0467 · Cited by 51 · cited 8×
“NBDs bind and hydrolyze ATP to trigger conformational changes in the TMDs, resulting in unidirectio al transport across the membrane [1].”
BackgroundInfluentialEvaluation of pharmacological induction of fatty acid β-oxidation in X-linked Adrenoleukodystrophy
McGuinness, M. C., Zhang, H.-P., & Smith, K. D. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3239 · Cited by 51 · cited 1×
“This set the basis for a new therapeutic strategy for X-ALD patients aiming at inducing ABCD2 expression with pharmacological, hormonal, or nutritional management [41,42].”
BackgroundAutophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy
Launay, N., Aguado, C., Fourcade, S., Ruiz, M., Grau, L., Riera, J., Guilera, C., Giròs, M., Ferrer, I., Knecht, E., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1378-8 · Cited by 51
Lu, J., Barron‐Casella, E. A., Brose, R. D., Heinzer, A. K., Moser, A. B., Bentley, K. L. D. M., Wand, G. S., McGuinness, M. C., Pei, Z., Watkins, P. A., et al. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700512 · Cited by 49
Casasnovas, C., Ruíz, M., Schlüter, A., Naudí, A., Fourcade, S., Veciana, M., Castañer, S., Albertí, A., Bargalló, N., Johnson, M. R., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00735-2 · Cited by 47 · cited 2×
“These hopeful results led to a prospective phase II pilot study that was carried out for 13 AMN patients treated with a cocktail of antioxidant molecules [93].”
BackgroundResultStrachan, L. R., Stevenson, T. J., Freshner, B., Keefe, M. D., Miranda Bowles, D., & Bonkowsky, J. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx249 · Cited by 46 · cited 1×
“Indeed, Abcd1 (the zebrafish ortholog of ABCD1), is expressed during development in spinal cord and in the central nervous system especially in the oligodendrocytes and motor neuron precursors, but also in the interrenal gland (functional equivalent of the adrenal cortex) [118].”
BackgroundHama, K., Fujiwara, Y., Hayama, T., Ozawa, T., Nozawa, K., Matsuda, K., Hashiguchi, Y., & Yokoyama, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-85603-w · Cited by 46 · cited 1×
“Recently, VLCFA accumulation was associated with colorectal cancer [106].”
BackgroundThyroid Hormone Induction of the Adrenoleukodystrophy-Related Gene (ABCD2)
Fourcade, S., Savary, S., Gondcaille, C., Berger, J., Netik, A., Cadepond, F., El‐Etr, M., Molzer, B., & Bugaut, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1296 · Cited by 45
Self-citationZhang, X., De Marcos Lousa, C., Schutte-Lensink, N., Ofman, R., Wanders, R. J., Baldwin, S. A., Baker, A., Kemp, S., & Theodoulou, F. L. (2011) · Biochemical Journal · doi:10.1042/bj20110249 · Cited by 43 · cited 1×
“thaliana CTS mutant cannot restore the germination and establishment, whereas human ABCD2 only restores the germination phenotype [113].”
BackgroundPeroxisomal Membrane Contact Sites in Mammalian Cells
Chen, C., Li, J., Qin, X., & Wang, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00512 · Cited by 43
Liver X Receptor α Interferes with SREBP1c-mediated Abcd2 Expression
Weinhofer, I., Kunze, M., Rampler, H., Bookout, A. L., Forss-Petter, S., & Berger, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509450200 · Cited by 42
Roerig, P., Mayerhofer, P., Holzinger, A., & Gärtner, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02235-9 · Cited by 40
Identification of a New Fatty Acid Synthesis-Transport Machinery at the Peroxisomal Membrane
Hillebrand, M., Gersting, S. W., Lotz-Havla, A. S., Schäfer, A., Rosewich, H., Valerius, O., Muntau, A. C., & Gärtner, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.272732 · Cited by 40
Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy
Raas, Q., van de Beek, M.-C., Forss-Petter, S., Dijkstra, I. M. E., Deschiffart, A., Freshner, B. C., Stevenson, T. J., Jaspers, Y. R. J., Nagtzaam, L., Wanders, R. J. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142500 · Cited by 40
Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy
Baarine, M., Khan, M., Singh, A., & Singh, I. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143238 · Cited by 38
Singh, J., Khan, M., & Singh, I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017491 · Cited by 37 · cited 1×
“This model should be very useful for studying the mechanisms of astrocyte activation and was used to screen therapeutic compounds such as SAHA, an HDAC inhibitor that normalizes ROS production as well as iNOS and TNF expression [53].”
MethodInduction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics
Genin, E. C., Gondcaille, C., Trompier, D., & Savary, S. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.04.006 · Cited by 37 · cited 1×
“In addition, efforts to find pharmacological strategies targeting oxidative stress, inflammation, or compensatory mechanisms (antioxidant cocktail [93], leriglitazone [94], sobetirome [50,54,55]) are still present.”
BackgroundSelf-citationEffect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters
Leclercq, S., Skrzypski, J., Courvoisier, A., Gondcaille, C., Bonnetain, F., André, A., Chardigny, J., Bellenger, S., Bellenger, J., Narce, M., et al. (2008) · Biochimie · doi:10.1016/j.biochi.2008.05.022 · Cited by 37
Self-citationLiu, J., Sabeva, N. S., Bhatnagar, S., Li, X.-A., Pujol, A., & Graf, G. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m900237-jlr200 · Cited by 36 · cited 1×
“Further studies using the Abcd2 null mice demonstrated a specific role in MUFA transport, especially for erucic acid (C22:1 n-9) in adipose tissue [59,60] and an extended role in FA homeostasis [61].”
BackgroundSivachenko, A., Gordon, H. B., Kimball, S. S., Gavin, E., Bonkowsky, J. L., & Letsou, A. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.022244 · Cited by 34
Benedetti, E., Galzio, R. J., Laurenti, G., D’Angelo, B., Melchiorre, E., Cifone, M. G., Fanelli, F., Muzi, P., Coletti, G., Alecci, M., et al. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300121 · Cited by 33 · cited 1×
“On the contrary, ABCD1 and ABCD3 were found upregulated in breast carcinoma [104], and a positive correlation was observed between ABCD3 expression and glioma tumor grades [105].”
BackgroundWang, X.-M., Yik, W. Y., Zhang, P., Lu, W., Dranchak, P. K., Shibata, D., Steinberg, S. J., & Hacia, J. G. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt130 · Cited by 33
Probing substrate-induced conformational alterations in adrenoleukodystrophy protein by proteolysis
Guimarães, C. P., Sá-Miranda, C., & Azevedo, J. E. (2005) · Journal of Human Genetics · doi:10.1007/s10038-004-0226-4 · Cited by 32 · cited 1×
“It was proved, using protease protection assays, that acyl-CoAs but not free FAs bind to the TMD of the transporter [70].”
BackgroundRole of family D ATP-binding cassette transporters (ABCD) in cancer
Hlaváč, V., & Souček, P. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150114 · Cited by 32
Elsnerová, K., Bartáková, A., Tihlarik, J., Bouda, J., Rob, L., Škapa, P., Hruda, M., Gut, I., Mohelníková-Duchoňová, B., Souček, P., et al. (2017) · Journal of Cancer · doi:10.7150/jca.20766 · Cited by 32 · cited 1×
“melanoma [98] and renal cell carcinoma [99], ABCD2 in breast cancer [100], and ABCD3 in ovarian cancer [101] and colorectal cancer [102].”
BackgroundLipid rafts are essential for peroxisome biogenesis in HepG2 cells†
Woudenberg, J., Rembacz, K. P., Hoekstra, M., Pellicoro, A., van den Heuvel, F. A. J., Heegsma, J., van IJzendoorn, S. C. D., Holzinger, A., Imanaka, T., Moshage, H., et al. (2010) · Hepatology · doi:10.1002/hep.23684 · Cited by 31 · cited 2×
“Surprisingly, ABCD1 and ABCD3 were found in different detergent-resistant microdomains [29], implying that these proteins have a different environment in the peroxisomal lipid bilayer, questioning the biological relevance of the ABCD1 and ABCD3 heterodimers.”
BackgroundFourcade, S., Goicoechea, L., Parameswaran, J., Schlüter, A., Launay, N., Ruíz, M., Seyer, A., Colsch, B., Calingasan, N. Y., Ferrer, I., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12869 · Cited by 30
Evaluation of the therapeutic potential of PPARα agonists for X-linked adrenoleukodystrophy
Rampler, H., Weinhofer, I., Netik, A., Forss‐Petter, S., Brown, P. J., Oplinger, J. A., Bugaut, M., & Berger, J. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.09.002 · Cited by 29
Peroxisomal ATP-binding cassette transporters form mainly tetramers
Geillon, F., Gondcaille, C., Raas, Q., Dias, A. M. M., Pecqueur, D., Truntzer, C., Lucchi, G., Ducoroy, P., Falson, P., Savary, S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772806 · Cited by 29 · cited 7×
“with tandem mass spectrometry (modified from [28]).”
BackgroundMethodInfluentialSelf-citationVorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy
Zierfuss, B., Weinhofer, I., Kühl, J., Köhler, W., Bley, A. E., Zauner, K., Binder, J., Martinović, K., Seiser, C., Hertzberg, C., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51015 · Cited by 27 · cited 1×
“Therefore, human monocytes can be used to study the inflammatory process and identify compounds capable of inducing ABCD2 expression, correcting VLCFA level, β-oxidation, and inflammatory features [44,58].”
BackgroundLannuzel, A., Aubourg, P. R., & Tardieu, M. (1998) · European Journal of Paediatric Neurology · doi:10.1016/1090-3798(98)01002-7 · Cited by 26
Kawaguchi, K., Mukai, E., Watanabe, S., Yamashita, A., Morita, M., So, T., & Imanaka, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-81949-3 · Cited by 25 · cited 1×
“provided further proof of the transport mechanism [74].”
BackgroundMakkar, R. S., Contreras, M. A., Paintlia, A. S., Smith, B. T., Haq, E., & Singh, I. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.05.003 · Cited by 24
Structure-Function Analysis of Peroxisomal ATP-binding Cassette Transporters Using Chimeric Dimers
Geillon, F., Gondcaille, C., Charbonnier, S., Van Roermund, C. W., Lopez, T. E., Dias, A. M. M., Pais de Barros, J.-P., Arnould, C., Wanders, R. J., Trompier, D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575506 · Cited by 24 · cited 3×
“Experiments in mammalian cells confirmed such substrate preference [19,20].”
BackgroundSelf-citationLXR antagonists induce ABCD2 expression
Gondcaille, C., Genin, E. C., Lopez, T. E., Dias, A. M. M., Geillon, F., Andreoletti, P., Cherkaoui‐Malki, M., Nury, T., Lizard, G., Weinhofer, I., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.003 · Cited by 23
Self-citationThe absence of ABCD2 sensitizes mice to disruptions in lipid metabolism by dietary erucic acid
Liu, J., Liang, S., Liu, X., Brown, J. A., Newman, K. E., Sunkara, M., Morris, A. J., Bhatnagar, S., Li, X., Pujol, A., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m022160 · Cited by 23 · cited 1×
“Further studies using the Abcd2 null mice demonstrated a specific role in MUFA transport, especially for erucic acid (C22:1 n-9) in adipose tissue [59,60] and an extended role in FA homeostasis [61].”
BackgroundCoppa, A., Guha, S., Fourcade, S., Parameswaran, J., Ruiz, M., Moser, A. B., Schlüter, A., Murphy, M. P., Lizcano, J. M., Miranda-Vizuete, A., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.177 · Cited by 23
van Roermund, C. W. T., IJlst, L., Baker, A., Wanders, R. J. A., Theodoulou, F. L., & Waterham, H. R. (2020) · FEBS Letters · doi:10.1002/1873-3468.13974 · Cited by 23 · cited 2×
“When it comes to the fate of the free CoA, they are released in the peroxisomal lumen, as revealed using isolated peroxisomes from Saccharomyces cerevisiae [75].”
BackgroundAbnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer
Zhang, Y., Zhang, Y., Wang, J., Yang, J., & Yang, G. (2020) · Oncology Letters · doi:10.3892/ol.2020.11463 · Cited by 21 · cited 2×
“melanoma [98] and renal cell carcinoma [99], ABCD2 in breast cancer [100], and ABCD3 in ovarian cancer [101] and colorectal cancer [102].”
BackgroundPredictive Structure and Topology of Peroxisomal ATP-Binding Cassette (ABC) Transporters
Andreoletti, P., Raas, Q., Gondcaille, C., Cherkaoui‐Malki, M., Trompier, D., & Savary, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071593 · Cited by 20 · cited 3×
“In 2017, we proposed a structural model of human ABCD1 based on the crystal structure of the mitochondrial ABC transporter ABCB10, which shows not only the putative structure of ABCD1 in a membrane c ntext but also t e complex in ricacy of α-helices that constit te the whole trans embrane domain (Figure 2) [17].”
BackgroundMethodInfluentialSelf-citationRegulation of the adrenoleukodystrophy-related gene (ABCD2): Focus on oxysterols and LXR antagonists
Trompier, D., Gondcaille, C., Lizard, G., & Savary, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.025 · Cited by 19
Self-citationEtiology and treatment of adrenoleukodystrophy: new insights from Drosophila
Gordon, H. B., Valdez, L., & Letsou, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031286 · Cited by 19
Trompier, D., & Savary, S. (2013) · Colloquium Series on The Genetic Basis of Human Disease · doi:10.4199/c00075ed1v01y201303gbd004 · Cited by 18
Self-citationPaton, B. C., Heron, S. E., NELSON, P. V., Morris, C. P., & Poulos, A. (1997) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)64247-5 · Cited by 17 · cited 1×
“Although mutations were found in the ABCD3 gene of a Zellweger patient [64], further evidence showed that ABCD3 has no link with peroxisomal biogenesis and is definitively not associated with Zellweger Syndrome [95].”
BackgroundSouček, P., Hlaváč, V., Elsnerová, K., Václavíková, R., Koževnikovová, R., & Rauš, K. (2015) · Physiological Research · doi:10.33549/physiolres.933212 · Cited by 14 · cited 1×
“melanoma [98] and renal cell carcinoma [99], ABCD2 in breast cancer [100], and ABCD3 in ovarian cancer [101] and colorectal cancer [102].”
BackgroundPharmacological Complementation Remedies an Inborn Error of Lipid Metabolism
Hartley, M. D., Shokat, M. D., DeBell, M. J., Banerji, T., Kirkemo, L. L., & Scanlan, T. S. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.02.008 · Cited by 13
A novel cell model to study the function of the adrenoleukodystrophy-related protein
Gueugnon, F., Volodina, N., Taouil, J. E., Lopez, T. E., Gondcaille, C., Grand, A. S.-L., Mooijer, P. A. W., Kemp, S., Wanders, R. J. A., & Savary, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.152 · Cited by 12
Self-citationDownregulation of ABCD1 in Human Renal Cell Carcinoma
Hour, T., Kuo, Y.-Z., Liu, G., Kang, W.-Y., Huang, C., Tsai, Y., Wu, W., Huang, S., & Pu, Y. (2009) · The International Journal of Biological Markers · doi:10.5301/jbm.2009.3280 · Cited by 12 · cited 1×
“melanoma [98] and renal cell carcinoma [99], ABCD2 in breast cancer [100], and ABCD3 in ovarian cancer [101] and colorectal cancer [102].”
BackgroundSaid, M., Battaglia, E., Elass, A., Cano, V., Ziegler, J.-C., Cartier, A., Livertoux, M.-H., Vergoten, G., Fournel‐Gigleux, S., & Magdalou, J. (1998) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(1998)12:1<19::aid-jbt4>3.0.co;2-s · Cited by 11
Morita, M., Toida, A., Horiuchi, Y., Watanabe, S., Sasahara, M., Kawaguchi, K., So, T., & Imanaka, T. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06228 · Cited by 11
ABCD2 identifies a subclass of peroxisomes in mouse adipose tissue
Liu, X., Liu, J., Lester, J. D., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.046 · Cited by 10
Pharmacological Induction of Redundant Genes for a Therapy of X-ALD
Bugaut, M., Fourcade, S., Gondcaille, C., Gueugnon, F., Depreter, M., Roels, F., Netik, A., Berger, J., Martin, P. G. P., Pineau, T., et al. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_36 · Cited by 9 · cited 1×
“This set the basis for a new therapeutic strategy for X-ALD patients aiming at inducing ABCD2 expression with pharmacological, hormonal, or nutritional management [41,42].”
BackgroundSelf-citationWeber, F. D., Weinhofer, I., Einwich, A., Forss-Petter, S., Muneer, Z., Maier, H., Weber, W. H. A., & Berger, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103742 · Cited by 8 · cited 1×
“Therefore, human monocytes can be used to study the inflammatory process and identify compounds capable of inducing ABCD2 expression, correcting VLCFA level, β-oxidation, and inflammatory features [44,58].”
BackgroundSon, D., Quan, Z., Kang, P. J., Park, G., Kang, H., & You, S. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.10.003 · Cited by 7
Cuevas-Fernández, B., Fuentes-Almagro, C. A., & Peragón, J. (2019) · Nutrients · doi:10.3390/nu11020219 · Cited by 6
Forss-Petter, S. (1997) · doi:10.1002/(sici)1097-4547(19971201)50:5<829::aid-jnr19>3.0.co;2-w
Research works printed but not linked: 1
- Hebron, 2000, Defective phytanic and pristanic acids metabolism in PMP70 deficient mice results in defective nonshivering thermogenesis and dicarboxylic aciduria, J. Inherit. Metab. Dis., 23, 256
Cited by
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
Lepiarz-Raba, I., Gbadamosi, I., Florea, R., Paolicelli, R. C., & Jawaid, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00382-w · Cited by 90
Expression and Function of ABC Proteins in Fish Intestine
Bieczynski, F., Painefilú, J. C., Venturino, A., & Luquet, C. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.791834 · Cited by 60
The Physiological and Pathological Role of Acyl-CoA Oxidation
Szrok-Jurga, S., Czumaj, A., Turyn, J., Hebanowska, A., Świerczyński, J., Śledziński, T., & Stelmańska, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914857 · Cited by 62
“Three of these, ABCD1-3, are localized solely in peroxisomes and mediate the uptake of substrates into the peroxisome for βOX [115].”
BackgroundChen, Z.-P., Xu, D., Wang, L., Mao, Y.-X., Li, Y., Cheng, M.-T., Zhou, C.-Z., Hou, W.-T., & Chen, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-30974-5 · Cited by 37
Ghzaiel, I., Zarrouk, A., Nury, T., Libergoli, M., Florio, F., Hammouda, S., Ménétrier, F., Avoscan, L., Yammine, A., Samadi, M. H., et al. (2021) · Antioxidants · doi:10.3390/antiox10111772 · Cited by 44
“Abcd3 (ATP binding cassette subfamily D member) is a major component of the peroxisomal membrane and a common constituent of peroxisomes in different tissues [91,92] (Supplementary Figure S9).”
Background
Metadata
- Authors
- Tawbeh, A., Gondcaille, C., Trompier, D., & Savary, S.
- Affiliations
- Université de Bourgogne (FR)
- Corresponding author
- Savary, Stéphane
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-05
- Volume
- 22
- Issue
- 11
- Pages
- 6093
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8201181
- OpenAlex
- W3167214555
- Cited by
- 68
- References
- 178
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 17 · 2023: 13 · 2022: 10 · 2021: 2
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- peroxisomal ABC transporters, ABCD1, ABCD2, ABCD3, peroxisomal membrane, X-linked adrenoleukodystrophy, protein dimerization, protein-protein interaction network, cancer
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, ATP Binding Cassette Transporter, Subfamily D, Member 1, Adrenoleukodystrophy, Cholestasis, Fatty Acids, Humans, ATP-Binding Cassette Transporters, Peroxisomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.